Basel Medical Group Ltd announced it has regained compliance with Nasdaq's minimum bid price rule after its share price stayed at or above $1.00 for 10 consecutive business days ending July 7, 2026. The company was previously notified in January 2026 for failing to maintain this minimum price. Regaining compliance allows Basel Medical to maintain its Nasdaq listing, supporting its position as a leading healthcare provider in Singapore. The company continues to benefit from growth opportunities in the private healthcare sector across Southeast Asia.
Robert Kiyosaki criticized the US Treasury's decision to double long-term debt buybacks, calling it a form of quantitative easing or 'printing fake money.' He linked this move to inflation risks and a weakening dollar, urging investors to favor scarc...
BNB Chain is set to activate the Pasteur hard fork on August 25, 2026, introducing key upgrades like stronger bridge verification, safer validator key rotation, and increased block capacity. This follows earlier upgrades that improved network speed, ...
Arthur Hayes, co-founder of BitMEX, has turned bullish on Bitcoin, gold, and stocks following the US Treasury's decision to double its debt buyback program targeting longer-dated government bonds. Hayes sees this policy as a form of 'soft yield curve...
U.S. spot crypto ETFs for Bitcoin and Ethereum attracted $2.6 billion in net inflows last week, marking their strongest weekly performance in nearly 10 months. Bitcoin ETFs led with $1.92 billion inflows and increased trading volume, while Ethereum E...
Bitcoin's price pulled back to around $77,321 after a large whale sold 7,770 BTC worth $576.6 million over three days, raising concerns about short-term selling pressure. Despite this, Bitcoin's weekly gains remain strong, signaling ongoing investor ...
